Skip to content

Advertisement

  • Poster presentation
  • Open Access

Neurally adjusted ventilatory assistance in patients with critical illness polyneuromyopathy

  • 1,
  • 1,
  • 1,
  • 1,
  • 2,
  • 1,
  • 1 and
  • 1
Critical Care200913 (Suppl 1) :P110

https://doi.org/10.1186/cc7274

  • Published:

Keywords

  • Public Health
  • Heart Rate
  • Mechanical Ventilation
  • Arterial Pressure
  • Emergency Medicine

Introduction

Neurally adjusted ventilatory assistance (NAVA) delivers pressure (Paw) in proportion to the electrical activity of the diaphragm (EAdi). It is not known whether EAdi adequately reflects the respiratory drive in patients with critical illness polyneuromyopathy (CIPM) and would be sufficient to deliver assistance using NAVA.

Methods

Fifteen invasively ventilated patients (median (quartiles): 66 (59; 73) years old, APACHE II score 19 (17; 24)) with electrophysiologically documented CIPM were studied. A level of adequate unloading (NAVAAL) was identified daily based on the characteristic response in Paw and tidal volume (Vt) to stepwise increasing NAVA (titration) as previously described [1]. NAVAAL was used for a maximum of 72 hours.

Results

NAVAAL was implemented in 13 patients for 54 (40; 61) hours. Three patients were liberated from mechanical ventilation during the study. NAVA could not be used in two patients (diaphragm myoclonic; excessive respiratory drive). At NAVAAL peak inspiratory EAdi was reduced by 30 (25; 40)% compared with the lowest NAVA level used during the titration. The breathing pattern, heart rate, and mean arterial pressure remained stable during NAVA. See Table 1.

Table 1

 

PaO2/FiO2

PaCO2 (mmHg)

Mean inspiratory EAdi (μV)

Vt (ml/kg predicted body weight)

Respiratory rate (breaths/min)

NAVAAL day 1

227 (158; 286)

36 (30; 45)

5.6 (3.4; 7.8)

6.7 (5.8; 8.3)

30 (23; 34)

NAVAAL day 3

263 (212; 380)*

42 (39; 45)*

5.2 (2.9; 6.6)

6.5 (5.4; 7.6)

27 (22; 35)

Data presented as median (quartiles). * P < 0.05 vs. day 1.

Conclusion

EAdi was sufficient to use NAVA in most of our patients with moderate to severe CIPM. Implementation of a titrated NAVA level for up to 72 hours resulted in low Vt, improved oxygenation over time, and stable cardiorespiratory function.

Declarations

Acknowledgements

Supported by the Swiss National Science Foundation 3200B0-113478/1.

Authors’ Affiliations

(1)
University Hospital Bern, Switzerland
(2)
St Michael's Hospital, Toronto, ON, Canada

References

  1. Brander L, et al.: Titration and implementation of neurally adjusted ventilatory assist in critically ill patients. Chest 2008, in press.Google Scholar

Copyright

© Tuchscherer et al; licensee BioMed Central Ltd. 2009

This article is published under license to BioMed Central Ltd.

Advertisement